What serious adverse reactions happened during this study?
None of the participants had a serious adverse reaction or died because of a
serious adverse reaction during the study.
What adverse reactions happened during this study?
The most common adverse reaction was low blood sugar.
The table below shows the adverse reactions that happened in the participants
during the study. Same participants may have had more than 1 adverse reaction.
Adverse reactions
Saxagliptin Sitagliptin Placebo
(out of 112 (out of 115 (out of 120
Adverse reaction participants) participants) participants)
Low blood sugar 0.0% (0) 1.7% (2) 0.0% (0)
Bloating 0.9% (1) 0.0% (0) 0.0% (0)
Vomiting 0.9% (1) 0.0% (0) 0.0% (0)
Skin irritation caused by an allergy 0.9% (1) 0.0% (0) 0.0% (0)
Rash 0.9% (1) 0.0% (0) 0.0% (0)
Nausea 0.0% (0) 0.9% (1) 0.0% (0)
Heart failure 0.0% (0) 0.9% (1) 0.0% (0)
How has this study helped patients and
researchers?
This study helped researchers learn more about if saxagliptin affects heart function
in participants with T2DM and heart failure. It also helped researchers learn about
the safety of saxagliptin.
Researchers look at the results of many studies to decide which treatments work
best and are safest. This summary shows only the main results from this 1 study.
Other studies may provide new information or different results.
Further clinical studies with saxagliptin are not planned.
11 | Clinical Study Results